Skip to Content
Center for International Blood and Marrow Transplant Research

LY17-01b

Main Content

Clinical outcomes of patients age ?65 undergoing allogeneic hematopoietic cell transplant for non-hodgkin lymphoma.

Study #: LY17-01b

Study Status: Published

Presentation(s)

2019, EBMT (Oral)
2018, Tandem (Oral)

Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: A time-trend analysis.

Citation

Shah NN, Ahn KW, Litovich C, Sureda A, Kharfan-Dabaja MA, Awan FT, Ganguly S, Gergis U, Inwards D, Karmali R, Lazaryan A, Lekakis L, Munshi P, Nathan S, Saad AA, Solh M, Steinberg A, Vij R, Wood WA, Fenske TS, Smith S, Hamadani M.

Blood Cancer Journal. 2019, Dec 03: 9(12): 9(12):97. doi: 10.1038/s41408-019-0261-1. Epub 2019, Dec 03. PMCID:PMC6890709.

PubMed

PMID: 31796726

Abstract

Correction: Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: A time-trend analysis.

Citation

Shah NN, Ahn KW, Litovich C, Sureda A, Kharfan-Dabaja MA, Awan FT, Ganguly S, Gergis U, Inwards D, Karmali R, Lazaryan A, Lekakis L, Munshi P, Nathan S, Saad AA, Solh M, Steinberg A, Vij R, Wood WA, Fenske TS, Smith S, Hamadani M.

Blood Cancer Journal. 2021, Apr 29: 11(4): 11(4):82. doi: 10.1038/s41408-021-00472-w. Epub 2021, Apr 29. PMCID:PMC8085088.

PubMed

PMID: 33927193

Abstract